 | • レポートコード：GIR201100569 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アルツハイマー病治療薬の世界市場を調査対象にし、アルツハイマー病治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ドネペジル、メマンチン、リバスチグミン）、用途別分析（初期～中等度、中等度～重度）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Allergan、Lundbeck、Daiichi Sankyo、Eisai、Johnson & Johnson、Novartis、Pfizer、Merz Pharma ・メーカー別販売量、売上、市場シェア ・アルツハイマー病治療薬の地域別市場分析 ・アルツハイマー病治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アルツハイマー病治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アルツハイマー病治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アルツハイマー病治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アルツハイマー病治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アルツハイマー病治療薬の種類別市場規模2015-2020：ドネペジル、メマンチン、リバスチグミン ・アルツハイマー病治療薬の用途別市場規模2015-2020：初期～中等度、中等度～重度 ・アルツハイマー病治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The Alzheimer’s Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Alzheimer’s Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -10.5%% in the forecast period of 2020 to 2025 and will expected to reach USD 1483.3 million by 2025, from USD 2314.5 million in 2019.
Market segmentation
Alzheimer’s Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alzheimer’s Disease Drug market has been segmented into
Donepezil
Memantine
Rivastigmine
By Application, Alzheimer’s Disease Drug has been segmented into:
Early to Moderate Stages
Moderate to Severe Stages
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alzheimer’s Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Alzheimer’s Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alzheimer’s Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Alzheimer’s Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Alzheimer’s Disease Drug Market Share Analysis
Alzheimer’s Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alzheimer’s Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alzheimer’s Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Alzheimer’s Disease Drug are:
Allergan
Lundbeck
Daiichi Sankyo
Eisai
Johnson & Johnson
Novartis
Pfizer
Merz Pharma
Among other players domestic and global, Alzheimer’s Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer’s Disease Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alzheimer’s Disease Drug, with price, sales, revenue and global market share of Alzheimer’s Disease Drug in 2018 and 2019.
Chapter 3, the Alzheimer’s Disease Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer’s Disease Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Alzheimer’s Disease Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Alzheimer’s Disease Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Alzheimer’s Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alzheimer’s Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Market Analysis by Application
1.3.1 Overview: Global Alzheimer’s Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Overview of Global Alzheimer’s Disease Drug Market
1.4.1 Global Alzheimer’s Disease Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lundbeck
2.2.1 Lundbeck Details
2.2.2 Lundbeck Major Business
2.2.3 Lundbeck SWOT Analysis
2.2.4 Lundbeck Product and Services
2.2.5 Lundbeck Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Daiichi Sankyo
2.3.1 Daiichi Sankyo Details
2.3.2 Daiichi Sankyo Major Business
2.3.3 Daiichi Sankyo SWOT Analysis
2.3.4 Daiichi Sankyo Product and Services
2.3.5 Daiichi Sankyo Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eisai
2.4.1 Eisai Details
2.4.2 Eisai Major Business
2.4.3 Eisai SWOT Analysis
2.4.4 Eisai Product and Services
2.4.5 Eisai Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Product and Services
2.6.4 Novartis Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Product and Services
2.7.4 Pfizer Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merz Pharma
2.8.1 Merz Pharma Details
2.8.2 Merz Pharma Major Business
2.8.3 Merz Pharma Product and Services
2.8.4 Merz Pharma Alzheimer’s Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Alzheimer’s Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Alzheimer’s Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer’s Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Alzheimer’s Disease Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Alzheimer’s Disease Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer’s Disease Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Alzheimer’s Disease Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
4.3 Europe Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
4.5 South America Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Country
5.1.1 North America Alzheimer’s Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Alzheimer’s Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
5.3 Canada Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Alzheimer’s Disease Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Alzheimer’s Disease Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Alzheimer’s Disease Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
6.3 UK Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
6.4 France Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
6.5 Russia Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
6.6 Italy Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Alzheimer’s Disease Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Alzheimer’s Disease Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Alzheimer’s Disease Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
7.3 Japan Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
7.4 Korea Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
7.5 India Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
7.7 Australia Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Alzheimer’s Disease Drug Sales, Revenue and Market Share by Country
8.1.1 South America Alzheimer’s Disease Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Alzheimer’s Disease Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Alzheimer’s Disease Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Alzheimer’s Disease Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Alzheimer’s Disease Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Alzheimer’s Disease Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Alzheimer’s Disease Drug Sales and Market Share by Type (2015-2020)
10.2 Global Alzheimer’s Disease Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Alzheimer’s Disease Drug Price by Type (2015-2020)
11 Global Alzheimer’s Disease Drug Market Segment by Application
11.1 Global Alzheimer’s Disease Drug Sales Market Share by Application (2015-2020)
11.2 Global Alzheimer’s Disease Drug Revenue Market Share by Application (2015-2020)
11.3 Global Alzheimer’s Disease Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Alzheimer’s Disease Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Alzheimer’s Disease Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Alzheimer’s Disease Drug Market Forecast (2021-2025)
12.2.2 Europe Alzheimer’s Disease Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Alzheimer’s Disease Drug Market Forecast (2021-2025)
12.2.4 South America Alzheimer’s Disease Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Alzheimer’s Disease Drug Market Forecast (2021-2025)
12.3 Alzheimer’s Disease Drug Market Forecast by Type (2021-2025)
12.3.1 Global Alzheimer’s Disease Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Alzheimer’s Disease Drug Market Share Forecast by Type (2021-2025)
12.4 Alzheimer’s Disease Drug Market Forecast by Application (2021-2025)
12.4.1 Global Alzheimer’s Disease Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Alzheimer’s Disease Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Alzheimer's Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alzheimer's Disease Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Alzheimer's Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Allergan Basic Information, Manufacturing Base and Competitors
Table 9. Allergan Alzheimer's Disease Drug Major Business
Table 10. Allergan Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 11. Allergan SWOT Analysis
Table 12. Allergan Alzheimer's Disease Drug Product and Services
Table 13. Allergan Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 15. Lundbeck Alzheimer's Disease Drug Major Business
Table 16. Lundbeck Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 17. Lundbeck SWOT Analysis
Table 18. Lundbeck Alzheimer's Disease Drug Product and Services
Table 19. Lundbeck Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 21. Daiichi Sankyo Alzheimer's Disease Drug Major Business
Table 22. Daiichi Sankyo Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 23. Daiichi Sankyo SWOT Analysis
Table 24. Daiichi Sankyo Alzheimer's Disease Drug Product and Services
Table 25. Daiichi Sankyo Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Eisai Basic Information, Manufacturing Base and Competitors
Table 27. Eisai Alzheimer's Disease Drug Major Business
Table 28. Eisai Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 29. Eisai SWOT Analysis
Table 30. Eisai Alzheimer's Disease Drug Product and Services
Table 31. Eisai Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 33. Johnson & Johnson Alzheimer's Disease Drug Major Business
Table 34. Johnson & Johnson Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 35. Johnson & Johnson SWOT Analysis
Table 36. Johnson & Johnson Alzheimer's Disease Drug Product and Services
Table 37. Johnson & Johnson Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Novartis Basic Information, Manufacturing Base and Competitors
Table 39. Novartis Alzheimer's Disease Drug Major Business
Table 40. Novartis Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 41. Novartis SWOT Analysis
Table 42. Novartis Alzheimer's Disease Drug Product and Services
Table 43. Novartis Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Pfizer Basic Information, Manufacturing Base and Competitors
Table 45. Pfizer Alzheimer's Disease Drug Major Business
Table 46. Pfizer Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 47. Pfizer SWOT Analysis
Table 48. Pfizer Alzheimer's Disease Drug Product and Services
Table 49. Pfizer Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 51. Merz Pharma Alzheimer's Disease Drug Major Business
Table 52. Merz Pharma Alzheimer's Disease Drug Total Revenue (USD Million) (2018-2019)
Table 53. Merz Pharma SWOT Analysis
Table 54. Merz Pharma Alzheimer's Disease Drug Product and Services
Table 55. Merz Pharma Alzheimer's Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Alzheimer's Disease Drug Sales by Manufacturer (2018-2019) (M Units)
Table 57. Global Alzheimer's Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Alzheimer's Disease Drug Sales by Regions (2015-2020) (M Units)
Table 59. Global Alzheimer's Disease Drug Sales Market Share by Regions (2015-2020)
Table 60. Global Alzheimer's Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Alzheimer's Disease Drug Sales by Countries (2015-2020) (M Units)
Table 62. North America Alzheimer's Disease Drug Sales Market Share by Countries (2015-2020)
Table 63. North America Alzheimer's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Alzheimer's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 65. Europe Alzheimer's Disease Drug Sales by Countries (2015-2020) (M Units)
Table 66. Europe Alzheimer's Disease Drug Sales Market Share by Countries (2015-2020)
Table 67. Europe Alzheimer's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Alzheimer's Disease Drug Sales by Regions (2015-2020) (M Units)
Table 69. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Alzheimer's Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Alzheimer's Disease Drug Sales by Countries (2015-2020) (M Units)
Table 72. South America Alzheimer's Disease Drug Sales Market Share by Countries (2015-2020)
Table 73. South America Alzheimer's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Alzheimer's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Alzheimer's Disease Drug Sales by Countries (2015-2020) (M Units)
Table 76. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Alzheimer's Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Alzheimer's Disease Drug Revenue Market Share by Countries (2015-2020)
Table 79. Global Alzheimer's Disease Drug Sales by Type (2015-2020) (M Units)
Table 80. Global Alzheimer's Disease Drug Sales Share by Type (2015-2020)
Table 81. Global Alzheimer's Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 82. Global Alzheimer's Disease Drug Revenue Share by Type (2015-2020)
Table 83. Global Alzheimer's Disease Drug Sales by Application (2015-2020) (M Units)
Table 84. Global Alzheimer's Disease Drug Sales Share by Application (2015-2020)
Table 85. Global Alzheimer's Disease Drug Sales Forecast by Regions (2021-2025) (M Units)
Table 86. Global Alzheimer's Disease Drug Market Share Forecast by Regions (2021-2025)
Table 87. Global Alzheimer's Disease Drug Sales Forecast by Type (2021-2025) (M Units)
Table 88. Global Alzheimer's Disease Drug Market Share Forecast by Type (2021-2025)
Table 89. Global Alzheimer's Disease Drug Sales Forecast by Application (2021-2025)
Table 90. Global Alzheimer's Disease Drug Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Alzheimer's Disease Drug Picture
Figure 2. Global Sales Market Share of Alzheimer's Disease Drug by Type in 2019
Figure 3. Donepezil Picture
Figure 4. Memantine Picture
Figure 5. Rivastigmine Picture
Figure 6. Alzheimer's Disease Drug Sales Market Share by Application in 2019
Figure 7. Early to Moderate Stages Picture
Figure 8. Moderate to Severe Stages Picture
Figure 9. Global Alzheimer's Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Alzheimer's Disease Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Alzheimer's Disease Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global Alzheimer's Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Alzheimer's Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Alzheimer's Disease Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 35. Global Alzheimer's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Alzheimer's Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global Alzheimer's Disease Drug Revenue Market Share by Regions in 2018
Figure 38. North America Alzheimer's Disease Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe Alzheimer's Disease Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Alzheimer's Disease Drug Sales and Growth Rate (2015-2020)
Figure 41. South America Alzheimer's Disease Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Alzheimer's Disease Drug Sales and Growth Rate (2015-2020)
Figure 43. North America Alzheimer's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Alzheimer's Disease Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America Alzheimer's Disease Drug Sales Market Share by Countries in 2018
Figure 46. North America Alzheimer's Disease Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Alzheimer's Disease Drug Revenue Market Share by Countries in 2018
Figure 48. United States Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 49. Canada Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 50. Mexico Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 51. Europe Alzheimer's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Alzheimer's Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Alzheimer's Disease Drug Revenue Market Share by Countries in 2019
Figure 54. Germany Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 55. UK Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 56. France Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 57. Russia Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 58. Italy Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 59. Asia-Pacific Alzheimer's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Alzheimer's Disease Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Alzheimer's Disease Drug Revenue Market Share by Regions 2019
Figure 62. China Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 63. Japan Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 64. Korea Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 65. India Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 66. Southeast Asia Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 67. South America Alzheimer's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Alzheimer's Disease Drug Sales Market Share by Countries in 2019
Figure 69. South America Alzheimer's Disease Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 71. Argentina Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 72. Middle East and Africa Alzheimer's Disease Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Alzheimer's Disease Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Alzheimer's Disease Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 77. Egypt Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 78. Turkey Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 79. South Africa Alzheimer's Disease Drug Sales and Growth Rate (2015-2020) (M Units)
Figure 80. Global Alzheimer's Disease Drug Sales and Growth Rate (2021-2025) (M Units)
Figure 81. Global Alzheimer's Disease Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Alzheimer's Disease Drug Market Forecast (2021-2025) (M Units)
Figure 83. Europe Sales Alzheimer's Disease Drug Market Forecast (2021-2025) (M Units)
Figure 84. Asia-Pacific Sales Alzheimer's Disease Drug Market Forecast (2021-2025) (M Units)
Figure 85. South America Sales Alzheimer's Disease Drug Market Forecast (2021-2025) (M Units)
Figure 86. Middle East & Africa Sales Alzheimer's Disease Drug Market Forecast (2021-2025) (M Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
アルツハイマー病治療の世界市場 2020年 Market Overview The global Alzheimer's Disease Treatments market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer's Di…- アルツハイマー治療の世界市場 2020年 Market Overview The global Alzheimer’s Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alzheimer’s Therapeut…
- ベーチェット病治療薬の世界市場 2020年 Market Overview The global Behcet Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Behcet Disease Drug marke…
- シャルコー・マリー・トゥース病I型治療薬の世界市場 2020年 Market Overview The global Charcot-Marie-Tooth Disease Type I A Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cha…
- シャーガス病治療薬の世界市場 2020年 Market Overview The global Chagas Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chagas Disease Drug marke…